Controversies in Parotid Surgery: Is There Evidence? Part 1 (AMW) Session
2021 AAO-HNSF Annual Meeting & OTO Experience
The first mini seminar addresses controversial, but commonly encountered, issues in the management of benign and malignant parotid disease. We will review the data regarding (1) capsular dissection for pleomorphic adenoma and other benign salivary tumors; (2) superficial versus total parotidectomy for both primary malignancy and cutaneous metastases; (3) indications for neck dissection with primary parotid malignancy; (4) Management of the facial nerve in the setting of malignancy and (5) Complication rates and management. This session will allow for audience interaction and appeal to general otolaryngologists, academicians, and trainees, in addition to the head and neck oncological surgeon. This two-hour panel presentation will cover the topics above using a combination of didactics, audience response queries, and case-based examples.
Description
Learning Objective: 1. Use an evidence-based framework to determine appropriate use of capsular dissection in benign parotid disease. 2. Understand data-based approach for facial nerve management in malignancy and prevention/management of complications. 3. Understand indications for superficial vs total parotidectomy as well as the use of neck dissection in parotid malignancy. Faculty: Derrick Lin, MD(Nothing to Disclose), Bevan Yueh, MD, MPH(Nothing to Disclose), Samir Khariwala, MD(Nothing to Disclose), Richard Smith, MD(Nothing to Disclose), Kelly Michele Malloy, MD(Nothing to Disclose).
